Translating clinical notes into quantitative measures-a real-world observation on the response to cholinesterase inhibitors or selective serotonin reuptake inhibitors prescribed to outpatients with dementia using electronic medical records
Objective: Cholinesterase inhibitors (CEIs) are prescribed for dementia to maintain or improve memory. Selective serotonin reuptake inhibitors (SSRIs) are also prescribed to manage psychiatric symptoms seen in dementia. What proportion of outpatients actually responds to these drugs is still unclear...
Saved in:
Main Authors: | Jill S. Chotiyanonta (Author), Kengo Onda (Author), Milap A. Nowrangi (Author), Xin Li (Author), Xin Xu (Author), Roy Adams (Author), Constantine G. Lyketsos (Author), Peter Zandi (Author), Kenichi Oishi (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alzheimer's Disease and the Fornix
by: Constantine G. Lyketsos
Published: (2016) -
Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors
by: Chad Compagner, et al.
Published: (2021) -
Decreased Growth with Serotonin Reuptake Inhibitors
by: J Gordon Millichap
Published: (2002) -
Suicide attempt with selective serotonin reuptake inhibitor antidepressants
by: Sandra Cuenca Carcelén, et al.
Published: (2021) -
Role of selective serotonin reuptake inhibitors in prognosis dental implants: A retrospective study
by: Praveen Chandra, et al.
Published: (2021)